BBI Solutions (BBI), recent winners of the Made in the UK Export Award, will be attending the AACC Clinical Lab Expo in Philadelphia next month.
BBI, a leading manufacturer of raw materials and finished test platforms for the in-vitro diagnostics market, has been recognised for its exporting achievements over the past 25 years, winning the prestigious Made in the UK Export Award.
Whilst enjoying the company’s success, BBI Solutions Managing Director, Liam Taylor explained, “It has been events like the AACC Clinical Lab Expo that has contributed to our growing export sales, providing us with opportunities to engage with customers in new markets.”
This year, AACC, the world’s largest gathering of clinical lab professionals, is being held at the Pennsylvania Convention Center, Philadelphia on the 2nd - 4th August 2016. BBI will be showcasing their products and services on booth 2649.
Customers new and existing will be able to learn of BBI’s extended antibodies offering, which is on the verge of being launched to the market. New products to the range will include Vitamin D, NT-ProBNP, Procalcitonin and Thyroid TSH, T3, T4 and PTH, plus many more.
With cancer being one of the leading causes of morbidity and mortality worldwide and new case rates expected to rise by about 70% over the next two decades¹. BBI will have a focus on cancer at this year’s event, promoting their CA15-3 and CA125 antigens and antibodies.
BBI’s team are also excited to unveil new products soon to be launched to the portfolio including Troponin I antibodies and SCIPAC Clinical Specimen Panels. These new panels from BBI’s Biobank range will provide customers with a quantity of trusted patient samples for infectious disease.
Mr Taylor continued “AACC is a great platform to showcase new products to the market and we can’t wait to share these exciting new products with our customers.”
A team of BBI Solutions’ technical experts and commercial managers will be on hand at AACC to discuss BBI’s biological raw materials capabilities, as well as, their expertise in lateral flow assay development and manufacturing.
The team looks forward to welcoming attendees to booth 2649 and is offering an appointment booking service at its website http://www.bbisolutions.com/events/aacc2016/, so visitors can make the most of their time at this important event.
BBI Solutions is a leading supplier of biological raw materials and finished test platforms to the in-vitro diagnostic market. With almost 30 years' experience, we have grown from a small specialist company to a global business with manufacturing sites spanning three continents.
We deliver exceptional products and services that people ultimately rely on to enjoy a better quality of life.
Our range of raw materials includes antigens, antibodies, enzymes and serum and plasma products. We manufacture world renowned labels for lateral flow and ELISA, including our gold nanoparticles, horseradish peroxidase and alkaline phosphatase. Our glucose oxidase is used in over 5 billion blood glucose monitoring test strips every year.
We offer end to end outsourced development and manufacturing services across a number of lateral flow and related platforms. Over 25 years, we have successfully completed more than 250 projects. Using the latest technologies and platforms, customers have come to rely on BBI to deliver next generation assay performance.
BBI Solutions is part of the BBI Group.
Phone: +44 (0) 2920 747 232